Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FST-100 in Acute Adenoviral Conjunctivitis
NCT00941486Phase 2Terminated
- Sponsor
- Takeda
- Start
- Jun 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute adenoviral conjunctivitis comparing FST-100 with Vehicle (2 arms). Primary endpoint: Clinical cure at 1 year. Started Jun 2009; status: terminated.
02
Drugs
dexamethasone + povidone-iodine
03
Conditions
acute adenoviral conjunctivitis
Beyond the preview
Go deeper on NCT00941486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941486.